Urelumab
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Urelumab, covering 2016-12-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder [Phase 2]